MALTA – 7 April 2026 – Sasmar Pharma Limited is thrilled to announce the appointment of Dr. Alessandro Pappalardo as Head of Quality Assurance and Regulatory Affairs. In this global leadership role, Dr. Pappalardo will oversee the company’s quality management systems and regulatory strategies from its headquarters in Malta.
Dr. Pappalardo is a seasoned professional with extensive experience in key domestic and international roles. As a registered Qualified Person (QP) and Responsible Person (RP) with the Maltese authorities, he brings significant technical expertise and hands-on practice to the team. His appointment reinforces SASMAR’s ability to proactively manage complex regulatory landscapes, ensuring timely action and rigorous compliance with international standards across all global markets.
Andrew Soutter, Director at Sasmar Pharma, commented on the appointment:
"Having Dr. Pappalardo join SASMAR further supports our commitment to maintaining the highest standards of quality, safety, and regulatory compliance across our global product portfolio."
Dr. Pappalardo added:
"I am pleased to join SASMAR and look forward to contributing to the company’s ambitious growth objectives. In these challenging times, I believe that deep expertise, a commitment to excellence, and mutually beneficial partnerships will be the key differentiators as SASMAR continues its upward trajectory."
The entire SASMAR team welcomes Dr. Pappalardo and looks forward to his leadership in this pivotal role.
END
About SASMAR
SASMAR is a global pharmaceutical group of companies dedicated to improving the health and well-being of consumers through innovative products and high-quality manufacturing standards.
# # #